Greenridge Exploration Engages Dahrouge Consulting
VANCOUVER, British Columbia, March 06, 2024 (GLOBE NEWSWIRE) — Greenridge Exploration Inc. (“Greenridge” or the “Company”) (CSE: GXP | FRA: […]
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
SEATTLE and VANCOUVER, British Columbia, March 06, 2024 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical […]
The Shyft Group Achieves Ford Pro Upfitter Designation
NOVI, Mich., March 06, 2024 (GLOBE NEWSWIRE) — The Shyft Group, Inc. (NASDAQ: SHYF), the North American leader in specialty […]
Ocugen to Present at Investing in Cures Summit
MALVERN, Pa., March 06, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused […]
TSX News -
Else Nutrition Increases Canadian Market Penetration with Premier Ontario Retail Partner
VANCOUVER, British Columbia, March 06, 2024 (GLOBE NEWSWIRE) — ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) (“Else” or the “Company”), is proud […]
Kelly to Participate in the Sidoti Virtual Investor Conference
TROY, Mich., March 06, 2024 (GLOBE NEWSWIRE) — Kelly (Nasdaq: KELYA, KELYB), a leading global specialty talent solutions provider, today […]
Nexxen Reports Results for the Fourth Quarter and Year Ended December 31, 2023
Achieved full year 2023 Contribution ex-TAC and Adjusted EBITDA above the midpoints of the Company’s guidance Grew programmatic revenue 9% […]
Amesite Announces Launch of Active Shooter Preparedness App with World Renowned Expert Chris Grollnek
DETROIT, March 06, 2024 (GLOBE NEWSWIRE) — Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based […]
Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
INHBE lead clinical candidate selected; potential best-in-class treatment for obesity with potent and durable silencing, weight loss with no loss […]
Sensei Biotherapeutics to Present New Preclinical Data at Upcoming Scientific Conferences
BOSTON, March 06, 2024 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the […]
